Drugs (Pharmaceuticals) – Page 48

How Gilead Profited by Slow-Walking a Promising H.I.V. Therapy

Gilead delayed a new version of a drug, allowing it to extend the patent life of a blockbuster line of medications, internal documents show.

By Rebecca Robbins and Sheryl Gay Stolberg

Drugs (Pharmaceuticals) Factories and Manufacturing Food and Drug Administration Hospitals Pfizer Inc Shortages Tornadoes vis-video

Tornado Rips Through N.C. Site, Threatening Pfizer’s Drug Supplies

Extensive damage occurred at the company’s property in Rocky Mount, and many products used by hospitals appeared to have been affected. This could further exacerbate shortages.

By Christina Jewett

Drugs (Pharmaceuticals) Food and Drug Administration Respiratory Syncytial Virus (RSV) Sanofi SA

RSV Shot Is Approved for Infants

The respiratory virus is a global killer of babies and young children.

By Christina Jewett

donanemab Drugs (Pharmaceuticals) Leqembi (Drug) Proteins Research

Treating Alzheimer’s Very Early Offers Better Hope of Slowing Decline, Study Finds

A trial of donanemab, an experimental drug, found it modestly slowed the worsening of memory and thinking and worked better in patients at earlier stages and those under 75.

By Pam Belluck